about
Comparative analysis of viral RNA signatures on different RIG-I-like receptorsNedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus buddingThe biased nucleotide composition of HIV-1 triggers type I interferon response and correlates with subtype D increased pathogenicityBiosafety considerations for attenuated measles virus vectors used in virotherapy and vaccinationOncolytic virotherapy for human malignant mesothelioma: recent advancesPediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue VirusStructure of the Nucleoprotein Binding Domain of Mokola Virus PhosphoproteinOn dihydroorotate dehydrogenases and their inhibitors and usesStudy of human RIG-I polymorphisms identifies two variants with an opposite impact on the antiviral immune responseInhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunityProtection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein.A human coronavirus responsible for the common cold massively kills dendritic cells but not monocytesYeast lysates carrying the nucleoprotein from measles virus vaccine as a novel subunit vaccine platform to deliver Plasmodium circumsporozoite antigen.HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization.NRP/Optineurin Cooperates with TAX1BP1 to potentiate the activation of NF-kappaB by human T-lymphotropic virus type 1 tax protein.Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor.Identification of a small molecule that primes the type I interferon response to cytosolic DNA.The interaction of flavivirus M protein with light chain Tctex-1 of human dynein plays a role in late stages of virus replication.Enhanced gene silencing in cells cured of persistent virus infection by RNA interference.Species-specific impact of the autophagy machinery on Chikungunya virus infectionPediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses.High-throughput screening for broad-spectrum chemical inhibitors of RNA viruses.A chimeric human T-cell lymphotropic virus type 1 with the envelope glycoprotein of Moloney murine leukemia virus is infectious for murine cells.A phenotypic assay to identify Chikungunya virus inhibitors targeting the nonstructural protein nsP2.Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccine.RelAp43, a member of the NF-κB family involved in innate immune response against Lyssavirus infectionA single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV.The V protein of Tioman virus is incapable of blocking type I interferon signaling in human cells.[Stimulation of the antiviral innate immune response by pyrimidine biosynthesis inhibitors: a surprise of phenotypic screening].A field-proven yeast two-hybrid protocol used to identify coronavirus-host protein-protein interactions.Proteomic analysis of virus-host interactions in an infectious context using recombinant viruses.Original 2-(3-Alkoxy-1H-pyrazol-1-yl)azines Inhibitors of Human Dihydroorotate Dehydrogenase (DHODH)Live attenuated measles vaccine as a potential multivalent pediatric vaccination vector.A paediatric vaccination vector based on live attenuated measles vaccine.Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques.Comparative analysis of virus-host interactomes with a mammalian high-throughput protein complementation assay based on Gaussia princeps luciferase.A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice.The Golgi protein ACBD3, an interactor for poliovirus protein 3A, modulates poliovirus replicationDermaseptins and magainins: antimicrobial peptides from frogs' skin-new sources for a promising spermicides microbicides-a mini review.Large-scale nucleotide optimization of simian immunodeficiency virus reduces its capacity to stimulate type I interferon in vitro.
P50
Q24273258-5C0E4790-DFE4-4C4E-82D2-05A2227949A8Q24338693-F99AE355-7355-4B88-86B1-E3D67F75ACF9Q24498366-078838BB-6CC6-44B1-A3F8-7152BED53B56Q26700080-F07CDD40-C735-4CC6-8FE6-7183FEFA9150Q26826590-6C6D928C-4B62-43A2-9A32-CC26D803B4B6Q27484362-EC71E768-96DE-4CC4-9171-BDA2218E7902Q27658139-29D5E1FF-3D57-441A-9DAD-0145C3FE18ADQ28286480-595E2660-4ADC-44CD-8E44-57E752E99159Q28471590-C6453CBC-255F-4DE8-A236-456F7B348B5EQ28534057-D09AE89A-3EAC-4F40-9E91-AD27231CDFC8Q30359923-6BE1211D-DC9A-4727-B434-FB09CA05D65BQ30524109-003ECC7A-20B4-4170-A670-7FA99402923AQ32175658-46618609-8B28-43A9-8603-52D93EE5C767Q33308717-4EDA9496-4A8C-435E-BEA1-D7B5ED994714Q33483337-906B5B4A-8110-425D-BEAB-0EBB8AA02D73Q33508793-500A7F8D-CFFF-45BC-B0AA-6F0B4715DEB0Q33747178-28B1593F-2780-4D9A-8A7B-AEA0B0B053F8Q33964691-12568748-59D6-499B-A4A0-38B48F6AF657Q33990491-74DA396A-22E0-4F18-8F8E-03BB3156095AQ34036496-BB99794E-5DE5-4A30-BE49-87E0CB78621CQ34129876-3B951531-729A-4FF3-8655-64B9DE3FB111Q34230693-A7F54C67-E117-4666-99DE-893F82F0B194Q34343292-C09BBF75-285D-4846-AED2-63392FFBFE9DQ34415623-FBC5939E-F05E-43A3-92CC-4EC9A83578D6Q34505337-A570234F-CD66-4F07-839D-1F233A58EDB4Q34524628-A93A3CF9-F8BA-437F-B943-A2C73749E5F7Q34552313-2DD36BB2-B307-468B-A737-F41E2CF235BDQ34558886-FF3A4FDF-EE8C-4621-902E-3FA6B5FE08AAQ35556938-D5EF4774-FE70-4E37-A941-D21D43256149Q35568386-618D9F05-79BE-4F63-95C6-463B5F38E7CDQ35610639-32F03B2F-63C6-4495-B1E4-7B080B40920DQ35892823-7D3A0342-69B1-4408-B6DC-7C81BE71F851Q36202976-66CD6D8F-4047-4051-8E87-D865E759E339Q36243229-C64D6D74-CE22-45A1-98B1-077A47F1EF72Q36390054-53169021-CDFA-4846-B0B3-4872CE5F269FQ36536947-0C9C51DB-50E3-4173-A20C-7B6213623EF7Q36541009-F0192C8A-0208-454F-BA78-B63384021615Q37252575-D86402D9-C983-484A-80A2-57DA8AB3771DQ37412040-B55C2B9D-839F-4B38-A4F7-E78C96B50ED5Q37713911-CA0C1118-79FE-41D2-86E9-AB69AA9445D9
P50
description
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Frédéric Tangy
@ast
Frédéric Tangy
@en
Frédéric Tangy
@es
Frédéric Tangy
@nl
type
label
Frédéric Tangy
@ast
Frédéric Tangy
@en
Frédéric Tangy
@es
Frédéric Tangy
@nl
prefLabel
Frédéric Tangy
@ast
Frédéric Tangy
@en
Frédéric Tangy
@es
Frédéric Tangy
@nl
P214
P106
P21
P214
P31
P496
0000-0002-5937-5654
P735
P7859
viaf-32196467